RadNet Inc
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other r… Read more
Market Cap & Net Worth: RadNet Inc (RDNT)
RadNet Inc (NASDAQ:RDNT) has a market capitalization of $4.92 Billion ($4.92 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3161 globally and #2116 in its home market, demonstrating a 2.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RadNet Inc's stock price $63.63 by its total outstanding shares 77394253 (77.39 Million).
RadNet Inc Market Cap History: 2015 to 2026
RadNet Inc's market capitalization history from 2015 to 2026. Data shows growth from $478.30 Million to $4.92 Billion (25.03% CAGR).
Index Memberships
RadNet Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.19% | #72 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.01% | #386 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.36 Trillion | 0.30% | #83 of 602 |
Weight: RadNet Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
RadNet Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RadNet Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.71x
RadNet Inc's market cap is 2.71 times its annual revenue
0.52x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $499.19 Million | $884.53 Million | $7.23 Million | 0.56x | 69.04x |
| 2017 | $781.68 Million | $922.19 Million | $53.00K | 0.85x | 14748.72x |
| 2018 | $787.10 Million | $975.15 Million | $32.24 Million | 0.81x | 24.41x |
| 2019 | $1.57 Billion | $1.15 Billion | $14.76 Million | 1.36x | 106.47x |
| 2020 | $1.51 Billion | $1.07 Billion | -$14.84 Million | 1.41x | N/A |
| 2021 | $2.33 Billion | $1.32 Billion | $24.73 Million | 1.77x | 94.24x |
| 2022 | $1.46 Billion | $1.43 Billion | $10.65 Million | 1.02x | 136.84x |
| 2023 | $2.69 Billion | $1.62 Billion | $3.04 Million | 1.66x | 884.03x |
| 2024 | $5.41 Billion | $1.83 Billion | $2.79 Million | 2.95x | 1935.27x |
| 2025 | $5.52 Billion | $2.04 Billion | -$18.65 Million | 2.71x | N/A |
Competitor Companies of RDNT by Market Capitalization
Companies near RadNet Inc in the global market cap rankings as of March 18, 2026.
Key companies related to RadNet Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
RadNet Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, RadNet Inc's market cap moved from $478.30 Million to $ 4.92 Billion, with a yearly change of 25.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.92 Billion | -10.82% |
| 2025 | $5.52 Billion | +2.16% |
| 2024 | $5.41 Billion | +100.86% |
| 2023 | $2.69 Billion | +84.65% |
| 2022 | $1.46 Billion | -37.46% |
| 2021 | $2.33 Billion | +53.86% |
| 2020 | $1.51 Billion | -3.60% |
| 2019 | $1.57 Billion | +99.61% |
| 2018 | $787.10 Million | +0.69% |
| 2017 | $781.68 Million | +56.59% |
| 2016 | $499.19 Million | +4.37% |
| 2015 | $478.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of RadNet Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.92 Billion USD |
| MoneyControl | $4.92 Billion USD |
| MarketWatch | $4.92 Billion USD |
| marketcap.company | $4.92 Billion USD |
| Reuters | $4.92 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.